Cardiac Biomarkers Market by Technology, Product, End-user, and Geography - Forecast and Analysis - 2023-2027

Published: Feb 2023 Pages: 177 SKU: IRTNTR74940

Cardiac Biomarker Market Forecast 2023-2027

The Global Cardiac Biomarkers Market size is estimated to grow by USD 7.88 billion at a CAGR of 12.6% between 2022 and 2027.  The growth of the cardiac biomarkers market depends on several factors, including the increasing prevalence of CVDs, the growing geriatric population, and the rising number of M&A and new product launches. However, the market growth may be restrained due to market challenges such as the high cost of diagnostic products. However, market players are working on opportunities such as the use of digital health in rapid diagnostics for POC and technological advancement to cut down the cost, which will boost the growth of the market.

 It also includes an in-depth analysis of drivers, trends, and challenges. 

What will be the size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample!

Market Segmentation

This market research report extensively covers market segmentation by technology (conventional laboratory testing and POC testing), product (troponin, BNP and NT-proBNP, CK-MB, myoglobin, and others), end-user (hospitals, clinics, and diagnostic laboratories), and geography (North America, Europe, Asia, and Rest Of World (ROW)).

Market Dynamics and Customer Landscape

The market encompasses substances or molecules that are indicative of heart conditions, including chronic disorders and acute coronary syndromes such as heart attack and failure. The market is driven by the need for early detection of cardiovascular conditions and abnormality in cardiac functioning. Biomarkers such as enzymes and hormones play a crucial role in diagnosing critical cardiac conditions like Atherosclerosis. Healthcare providers rely on hospital laboratories and point-of-care testing facilities for accurate diagnostic results. The market is influenced by the growing elderly population, prompting increased focus on clinical research studies and epidemiological studies to identify new biomarkers. Access to biological samples from a diverse patient base is essential for developing effective diagnostic tools and treatments for cardiac diseases. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Drivers

The Increasing prevalence of CVDs is notably driving the market growth. The market has experienced significant growth due to the increasing prevalence of cardiovascular diseases, particularly in countries like the US. Approximately 6.5 million individuals aged 40 and above in the US are affected by Peripheral Arterial Disease (PAD), with equal prevalence among men and women. Factors contributing to this trend include low awareness, smoking, high prevalence of obesity, diabetes, high cholesterol, and high blood pressure. In hospital laboratories, cardiac biomarkers such as myoglobin, natriuretic peptides, ischemia-modified albumin, and novel substances are used to identify myocardial infarction, microvascular dysfunction, and ischemia. These markers are essential for patient care on a patient-specific basis, enabling personalized medicine and improving the standard of care. Quality control, sensitivity, specificity, and regulatory issues are crucial considerations in the collection, detection, and storage of these biomarkers, which have storage limits and require specific conditions to maintain accuracy. Hence, these factors are expected to drive market growth during the forecast period.

Significant Market Trends

The increased focus on personalized medicine is the primary trend in the market. The market is expanding due to the rising prevalence of conditions such as high blood pressure, high cholesterol, obesity, and physical inactivity. These factors increase the risk of heart diseases, including myocardial infarction and ischemia. Hospital laboratories utilize various markers, such as C-reactive protein (CRP), myoglobin, natriuretic peptides, ischemia-modified albumin (IMA), and novel cardiac biomarkers, for diagnosing and monitoring heart conditions. These markers provide valuable information on an individual patient's profile, enabling personalized medicine and patient-specific treatment plans. Protein detection, sensitivity, specificity, and quality control are essential aspects of cardiac biomarker testing. Regulatory issues and storage conditions, including sample collection and storage limits, also play a significant role in ensuring accurate and reliable results. Smoking and other substances or molecules can influence the levels of these biomarkers, making it crucial for the standard of care to consider these factors in patient care. Hence, these factors are expected to drive demand for cardiac biomarkers in the forecast period.

Major Market Challenges

The shortage of skilled clinicians is a major challenge impeding market growth. The global shortage of cardiologists, including various specialties, persists in both developed and underdeveloped countries. In the US, for instance, there was a deficit of around 4,500 cardiologists in 2021 to fill private practice and academic positions, with this number projected to reach approximately 6,000 by 2025. This shortage can be attributed to several factors, such as consolidation among healthcare organizations, new maintenance of certification requirements, funding cuts for Graduate Medical Education and research, and declining physician reimbursements. Meanwhile, the market continues to expand due to the increasing prevalence of conditions like high blood pressure, high cholesterol, obesity, physical inactivity, and smoking. These conditions can lead to complications such as myocardial infarction, ischemia modified albumin, myoglobin, natriuretic peptides, microvascular dysfunction, and other cardiac issues. Hospital laboratories rely on these markers for patient care on a patient-specific basis, utilizing novel cardiac biomarkers for personalized medicine. Protein detection, sensitivity, and specificity are crucial for accurate diagnosis and quality control. Regulatory issues and sample collection procedures must also be addressed, along with storage conditions and storage limits to ensure the integrity of these substances or molecules. Hence, these factors may impede market growth due to the low adoption of these costly diagnostic products.

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers cardiac biomarker solutions such as BNP, CK-MB, Galectin 3, Myoglobin, and Troponin I.

The cardiac biomarker market report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

  • Abbott Laboratories
  • Advanced ImmunoChemical Inc.
  • BG Medicine Inc.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Boditech Med Inc.
  • Creative Diagnostics
  • Danaher Corp.
  • Diazyme Laboratories Inc.
  • F. Hoffmann La Roche Ltd.
  • Lepu Medical Technology Beijing Co. Ltd.
  • LifeSign LLC
  • LSI Medience Corp.
  • Noavaran Payesh Aani Salamat. Co.
  • Oy Medix Biochemica Ab
  • Randox Laboratories Ltd.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

By Technology

The market share growth of the conventional laboratory testing segment will be significant during the forecast period. In conventional laboratory or lab-based testing, a clinician takes a sample of bodily fluids or tissues from the patient and then ensures its packaging and safe transport. These samples are then shipped to a central laboratory to be analyzed by a skilled laboratory professional. Depending on the complexity of the laboratory test, the results take approximately 1-2 days to be processed, and it is then sent back to the clinician. These test results are shared with patients in person, by phone, by email, or via a patient portal.

Get a glance at the market contribution of various segments Request a PDF Sample

The conventional laboratory testing segment was valued at USD 4.01 billion in 2017. The process of lab-based testing takes up to a week, right from when the patient provides the sample until the results are delivered; the long time taken is mainly attributed to the need for proper packaging and shipping, lab capacity, test processing, and data sharing. Such factors are major factors for the declining growth of the conventional laboratory testing segment in the market in focus during the forecast period.

By Region

For more insights on the market share of various regions Request PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in North America is experiencing significant growth due to the high prevalence of cardiovascular diseases (CVDs), particularly in the context of acute coronary syndrome and chronic heart conditions. Factors driving market expansion include increasing healthcare expenditure on cardiac conditions, the aging population, and rising diagnostic procedures. Cardiac biomarkers, such as Cardiac troponin, CK-MB, and CRP, are essential components of cardiovascular medicine for early detection and disease management. These biomarkers, found in blood, play a crucial role in cardiac diagnostics, particularly in the context of heart attacks and heart failure. Archived specimens and advanced technologies are also contributing to market growth. The field of cardiology is witnessing numerous clinical research efforts to improve cardiovascular diagnostics and reduce heart-related deaths. Healthcare systems and technologies are increasingly adopting cardiac test kits and diagnostic solutions to enhance disease management and improve patient outcomes.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Technology Outlook 
    • Conventional laboratory testing
    • POC testing
  • Product Outlook 
    • Troponin
    • BNP and NT-proBNP
    • CK-MB
    • Myoglobin
    • Others
  • End-user Outlook 
    • Hospitals and clinics
    • Diagnostic laboratories
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Market Analyst Overview

The market refers to the industry focused on the production, development, and distribution of various biomarkers used for the diagnosis and prognosis of cardiac diseases. These biomarkers include Cardiac Troponins (cTn), Brain Natriuretic Peptide (BNP), and Creatine Kinase-MB (CK-MB). Cardiac Troponins are proteins found in the heart that are released into the bloodstream when the heart muscle is damaged. BNP is a hormone produced by the heart in response to the stretching of the cardiac muscle fibers. CK-MB is an enzyme that is released into the bloodstream when there is damage to the heart or skeletal muscle. The use of these cardiac biomarkers in the diagnosis and treatment of cardiac diseases such as myocardial infarction, heart failure, and cardiomyopathy is increasing, driving the growth of the Cardiac Biomarkers market.

Additionally, the development of more sensitive and specific assays for these biomarkers is expected to further fuel market growth. (Cardiac Biomarkers, cTn, BNP, CK-MB, diagnosis, prognosis, heart disease, myocardial infarction, heart failure, cardiomyopathy, growth, sensitive, specific). The market is witnessing significant growth driven by the need for early diagnosis of cardiovascular disorders and Point of care testing facilities. With the emergence of the novel coronavirus, there's a heightened awareness of the high risks associated with conditions like congestive heart failure, myocarditis, and hypertension. Hospitals, especially in Spain, have reported a decline in the number of patients visiting emergency departments for cardiac issues. This trend has led to a reduction in admissions and a shift towards more lifestyle changes to manage cardiovascular health. The market is also seeing advancements in Point-of-Care Biomarker Tests, offering rapid and convenient diagnostics.

Market Scope

Report Coverage

Details

Page number

177

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12.6%

Market growth 2023-2027

USD 7.88 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

11.43

Regional analysis

North America, Europe, Asia, and the Rest of World (ROW)

Performing market contribution

North America at 40%

Key countries

US, Germany, UK, China, and India

Competitive landscape

 Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Advanced ImmunoChemical Inc., BG Medicine Inc., Bio Rad Laboratories Inc., bioMerieux SA, Boditech Med Inc., Creative Diagnostics, Danaher Corp., Diazyme Laboratories Inc., F. Hoffmann La Roche Ltd., Lepu Medical Technology Beijing Co. Ltd., LifeSign LLC, LSI Medience Corp., Noavaran Payesh Aani Salamat. Co., Oy Medix Biochemica Ab, Randox Laboratories Ltd., Response Biomedical Corp., Siemens Healthineers AG, Signosis Inc., AgPlus Diagnostics Ltd., and Tosoh Corp.

Market dynamics

Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Get access to Report Sample PDF !

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 08: Executive Summary – Chart on Incremental Growth
    • Exhibit 09: Executive Summary – Data Table on Incremental Growth
    • Exhibit 10: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 11: Parent market
    • Exhibit 12: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 13: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 14: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 15: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 17: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 18: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global cardiac biomarkers market 2017 - 2021
      • Exhibit 19: Historic Market Size – Data Table on Global cardiac biomarkers market 2017 - 2021 ($ million)
    • 4.2 Technology Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ million)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.4 End-user Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
    • 4.5 Geography Segment Analysis 2017 - 2021
      • Exhibit 23: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.6 Country Segment Analysis 2017 - 2021
      • Exhibit 24: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 25: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 26: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 27: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 28: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 29: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 30: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 31: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Technology

    • 6.1 Market segments
      • Exhibit 32: Chart on Technology - Market share 2022-2027 (%)
      • Exhibit 33: Data Table on Technology - Market share 2022-2027 (%)
    • 6.2 Comparison by Technology
      • Exhibit 34: Chart on Comparison by Technology
      • Exhibit 35: Data Table on Comparison by Technology
    • 6.3 Conventional laboratory testing - Market size and forecast 2022-2027
      • Exhibit 36: Chart on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 37: Data Table on Conventional laboratory testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 38: Chart on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 39: Data Table on Conventional laboratory testing - Year-over-year growth 2022-2027 (%)
    • 6.4 POC testing - Market size and forecast 2022-2027
      • Exhibit 40: Chart on POC testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 41: Data Table on POC testing - Market size and forecast 2022-2027 ($ million)
      • Exhibit 42: Chart on POC testing - Year-over-year growth 2022-2027 (%)
      • Exhibit 43: Data Table on POC testing - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Technology
      • Exhibit 44: Market opportunity by Technology ($ million)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 45: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 46: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 47: Chart on Comparison by Product
      • Exhibit 48: Data Table on Comparison by Product
    • 7.3 Troponin - Market size and forecast 2022-2027
      • Exhibit 49: Chart on Troponin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Data Table on Troponin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 51: Chart on Troponin - Year-over-year growth 2022-2027 (%)
      • Exhibit 52: Data Table on Troponin - Year-over-year growth 2022-2027 (%)
    • 7.4 BNP and NT-proBNP - Market size and forecast 2022-2027
      • Exhibit 53: Chart on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Data Table on BNP and NT-proBNP - Market size and forecast 2022-2027 ($ million)
      • Exhibit 55: Chart on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
      • Exhibit 56: Data Table on BNP and NT-proBNP - Year-over-year growth 2022-2027 (%)
    • 7.5 CK-MB - Market size and forecast 2022-2027
      • Exhibit 57: Chart on CK-MB - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Data Table on CK-MB - Market size and forecast 2022-2027 ($ million)
      • Exhibit 59: Chart on CK-MB - Year-over-year growth 2022-2027 (%)
      • Exhibit 60: Data Table on CK-MB - Year-over-year growth 2022-2027 (%)
    • 7.6 Myoglobin - Market size and forecast 2022-2027
      • Exhibit 61: Chart on Myoglobin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on Myoglobin - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on Myoglobin - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on Myoglobin - Year-over-year growth 2022-2027 (%)
    • 7.7 Others - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Others - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Product
      • Exhibit 69: Market opportunity by Product ($ million)

    8 Market Segmentation by End-user

    • 8.1 Market segments
      • Exhibit 70: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 71: Data Table on End-user - Market share 2022-2027 (%)
    • 8.2 Comparison by End-user
      • Exhibit 72: Chart on Comparison by End-user
      • Exhibit 73: Data Table on Comparison by End-user
    • 8.3 Hospitals and clinics - Market size and forecast 2022-2027
      • Exhibit 74: Chart on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Data Table on Hospitals and clinics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Chart on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
      • Exhibit 77: Data Table on Hospitals and clinics - Year-over-year growth 2022-2027 (%)
    • 8.4 Diagnostic laboratories - Market size and forecast 2022-2027
      • Exhibit 78: Chart on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Data Table on Diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Chart on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
      • Exhibit 81: Data Table on Diagnostic laboratories - Year-over-year growth 2022-2027 (%)
    • 8.5 Market opportunity by End-user
      • Exhibit 82: Market opportunity by End-user ($ million)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Exhibit 83: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Geographic Landscape

    • 10.1 Geographic segmentation
      • Exhibit 84: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 85: Data Table on Market share by geography 2022-2027 (%)
    • 10.2 Geographic comparison
      • Exhibit 86: Chart on Geographic comparison
      • Exhibit 87: Data Table on Geographic comparison
    • 10.3 North America - Market size and forecast 2022-2027
      • Exhibit 88: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 91: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 10.4 Europe - Market size and forecast 2022-2027
      • Exhibit 92: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 95: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 10.5 Asia - Market size and forecast 2022-2027
      • Exhibit 96: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 98: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 99: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 10.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 100: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 102: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 103: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 10.7 US - Market size and forecast 2022-2027
      • Exhibit 104: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 106: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 107: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 10.8 Germany - Market size and forecast 2022-2027
      • Exhibit 108: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 110: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 111: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 10.9 China - Market size and forecast 2022-2027
      • Exhibit 112: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 113: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 114: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 115: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 10.10 UK - Market size and forecast 2022-2027
      • Exhibit 116: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 117: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 118: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 119: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 10.11 India - Market size and forecast 2022-2027
      • Exhibit 120: Chart on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 121: Data Table on India - Market size and forecast 2022-2027 ($ million)
      • Exhibit 122: Chart on India - Year-over-year growth 2022-2027 (%)
      • Exhibit 123: Data Table on India - Year-over-year growth 2022-2027 (%)
    • 10.12 Market opportunity by geography
      • Exhibit 124: Market opportunity by geography ($ million)

    11 Drivers, Challenges, and Trends

    • 11.1 Market drivers
      • 11.2 Market challenges
        • 11.3 Impact of drivers and challenges
          • Exhibit 125: Impact of drivers and challenges in 2022 and 2027
        • 11.4 Market trends

          12 Vendor Landscape

          • 12.1 Overview
            • 12.2 Vendor landscape
              • Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
            • 12.3 Landscape disruption
              • Exhibit 127: Overview on factors of disruption
            • 12.4 Industry risks
              • Exhibit 128: Impact of key risks on business

            13 Vendor Analysis

            • 13.1 Vendors covered
              • Exhibit 129: Vendors covered
            • 13.2 Market positioning of vendors
              • Exhibit 130: Matrix on vendor position and classification
            • 13.3 Abbott Laboratories
              • Exhibit 131: Abbott Laboratories - Overview
              • Exhibit 132: Abbott Laboratories - Business segments
              • Exhibit 133: Abbott Laboratories - Key news
              • Exhibit 134: Abbott Laboratories - Key offerings
              • Exhibit 135: Abbott Laboratories - Segment focus
            • 13.4 BG Medicine Inc.
              • Exhibit 136: BG Medicine Inc. - Overview
              • Exhibit 137: BG Medicine Inc. - Product / Service
              • Exhibit 138: BG Medicine Inc. - Key offerings
            • 13.5 Bio Rad Laboratories Inc.
              • Exhibit 139: Bio Rad Laboratories Inc. - Overview
              • Exhibit 140: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 141: Bio Rad Laboratories Inc. - Key news
              • Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
            • 13.6 bioMerieux SA
              • Exhibit 144: bioMerieux SA - Overview
              • Exhibit 145: bioMerieux SA - Product / Service
              • Exhibit 146: bioMerieux SA - Key news
              • Exhibit 147: bioMerieux SA - Key offerings
            • 13.7 Boditech Med Inc.
              • Exhibit 148: Boditech Med Inc. - Overview
              • Exhibit 149: Boditech Med Inc. - Key offerings
            • 13.8 Creative Diagnostics
              • Exhibit 150: Creative Diagnostics - Overview
              • Exhibit 151: Creative Diagnostics - Product / Service
              • Exhibit 152: Creative Diagnostics - Key offerings
            • 13.9 Diazyme Laboratories Inc.
              • Exhibit 153: Diazyme Laboratories Inc. - Overview
              • Exhibit 154: Diazyme Laboratories Inc. - Product / Service
              • Exhibit 155: Diazyme Laboratories Inc. - Key offerings
            • 13.10 F. Hoffmann La Roche Ltd.
              • Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus
            • 13.11 Lepu Medical Technology Beijing Co. Ltd.
              • Exhibit 161: Lepu Medical Technology Beijing Co. Ltd. - Overview
              • Exhibit 162: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
              • Exhibit 163: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
            • 13.12 LifeSign LLC
              • Exhibit 164: LifeSign LLC - Overview
              • Exhibit 165: LifeSign LLC - Product / Service
              • Exhibit 166: LifeSign LLC - Key offerings
            • 13.13 LSI Medience Corp.
              • Exhibit 167: LSI Medience Corp. - Overview
              • Exhibit 168: LSI Medience Corp. - Product / Service
              • Exhibit 169: LSI Medience Corp. - Key offerings
            • 13.14 Randox Laboratories Ltd.
              • Exhibit 170: Randox Laboratories Ltd. - Overview
              • Exhibit 171: Randox Laboratories Ltd. - Product / Service
              • Exhibit 172: Randox Laboratories Ltd. - Key offerings
            • 13.15 Response Biomedical Corp.
              • Exhibit 173: Response Biomedical Corp. - Overview
              • Exhibit 174: Response Biomedical Corp. - Product / Service
              • Exhibit 175: Response Biomedical Corp. - Key offerings
            • 13.16 Siemens Healthineers AG
              • Exhibit 176: Siemens Healthineers AG - Overview
              • Exhibit 177: Siemens Healthineers AG - Business segments
              • Exhibit 178: Siemens Healthineers AG - Key news
              • Exhibit 179: Siemens Healthineers AG - Key offerings
              • Exhibit 180: Siemens Healthineers AG - Segment focus
            • 13.17 Signosis Inc.
              • Exhibit 181: Signosis Inc. - Overview
              • Exhibit 182: Signosis Inc. - Product / Service
              • Exhibit 183: Signosis Inc. - Key offerings

            14 Appendix

            • 14.1 Scope of the report
              • 14.2 Inclusions and exclusions checklist
                • Exhibit 184: Inclusions checklist
                • Exhibit 185: Exclusions checklist
              • 14.3 Currency conversion rates for US$
                • Exhibit 186: Currency conversion rates for US$
              • 14.4 Research methodology
                • Exhibit 187: Research methodology
                • Exhibit 188: Validation techniques employed for market sizing
                • Exhibit 189: Information sources
              • 14.5 List of abbreviations
                • Exhibit 190: List of abbreviations
              • investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                cardiac biomarkers market

                QUICK BUY

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis